Early safety check for potential c. diff drug in japanese volunteers
NCT ID NCT06639997
First seen Nov 19, 2025 · Last updated May 16, 2026 · Updated 27 times
Summary
This study tested a single dose of a new drug called AZD5148 in 16 healthy Japanese adults to see if it is safe and how the body processes it. The drug is being developed for Clostridioides difficile infection. Participants received either the drug or a placebo by injection. The study is complete and focused on safety and drug levels, not on treating the infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLOSTRIDIOIDES DIFFICILE INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Sumida-ku, 130-0004, Japan
Conditions
Explore the condition pages connected to this study.